Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease

被引：0
|
作者：
Tang, Mengyao [1 ,2 ]
Morieri, Mario Luca [3 ]
Kalim, Sahir [1 ,2 ]
Doria, Alessandro [2 ,4 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] Univ Padua, Dept Med, Padua, Italy
[4] Joslin Diabet Ctr, Res Div, Boston, MA 02215 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2025年
关键词：
diabetic kidney disease;
D O I：
10.1681/ASN.0000000620
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?
    Cervantes, Carlos Escobar
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (08): : 507 - 508
  • [2] SGLT2 inhibitors and GLP-1 receptor agonists: a sound combination
    De Block, Christophe
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05): : 349 - 352
  • [3] Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
    Li, Jiahua
    Albajrami, Oltjon
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (11): : 1678 - 1688
  • [4] Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Winiarska, Agata
    Knysak, Monika
    Nabrdalik, Katarzyna
    Gumprecht, Janusz
    Stompor, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [5] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Scott Cohen
    Hillel Sternlicht
    George L. Bakris
    Current Diabetes Reports, 2022, 22 : 213 - 218
  • [6] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Cohen, Scott
    Sternlicht, Hillel
    Bakris, George L.
    CURRENT DIABETES REPORTS, 2022, 22 (05) : 213 - 218
  • [7] GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?
    Nauck, Michael A.
    Meier, Juris J.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 963 - 964
  • [8] Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes
    Neuen, Brendon L.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (08) : 709 - 711
  • [9] SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
    Brown, Emily
    Heerspink, Hiddo J. L.
    Cuthbertson, Daniel J.
    Wilding, John P. H.
    LANCET, 2021, 398 (10296): : 262 - 276
  • [10] Combination therapy with SGLT2 inhibitors for diabetic kidney disease
    Cai, Yuwen
    Liu, Xin
    Xu, Gaosi
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
12345